Dare Bioscience (DARE) vs Quantum Biopharma (QNTM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Dare Bioscience (DARE) has outperformed Quantum Biopharma (QNTM) over the past year, losing 75.8% versus a loss of 77.6%. Over five years, DARE leads with a -98.1% price change compared with -98.5% for QNTM. Quantum Biopharma is the larger company by market cap ($8.3 million vs $8.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DARE | QNTM |
|---|---|---|
| Share price | $0.4074 | $1.29 |
| Market cap | $8.01M | $8.29M |
| 1-day change | -9.87% | -9.15% |
| YTD return | -78.89% | -82.33% |
| 1-year return | -75.75% | -77.60% |
| 5-year return | -98.10% | -98.51% |
| EPS (TTM) | $-0.61 | $-3.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.03M | — |
| Revenue growth (YoY) | +10429.36% | — |
| Net income (latest FY) | $-13.40M | — |
| Gross margin | 71.29% | — |
| Operating margin | -1315.51% | — |
| Net margin | -1300.66% | — |
| 52-week high | $3.78 | $12.42 |
| 52-week low | $0.406 | $1.26 |
| Distance from 52-week high | -89.22% | -89.61% |
| Analyst consensus | none | none |
| Avg. price target upside | +1944.67% | +851.16% |
| Average volume | 242.39K | 148.83K |
| Shares outstanding | 19.67M | 6.43M |
| Employees | 21 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Dare Bioscience
DARE stock →Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
About Quantum Biopharma
QNTM stock →Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Health Care · Biotechnology: Pharmaceutical Preparations
DARE vs QNTM FAQ
Which is bigger, Dare Bioscience or Quantum Biopharma?
Quantum Biopharma (QNTM) is larger, with a market capitalization of $8.29M compared with $8.01M for Dare Bioscience (DARE).
Which stock has performed better over the past year, DARE or QNTM?
DARE returned -75.75% over the past 12 months, compared with -77.60% for QNTM (price return, excluding dividends). Past performance does not predict future results.
Are Dare Bioscience and Quantum Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.